India · Delayed Price · Currency is INR Biopol Chemicals Statistics
Total Valuation
NSE:BIOPOL has a market cap or net worth of INR 502.45 million. The enterprise value is 681.05 million.
| Market Cap | 502.45M |
| Enterprise Value | 681.05M |
Important Dates
The last earnings date was Thursday, November 5, 2026.
| Earnings Date | Nov 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:BIOPOL has 10.81 million shares outstanding. The number of shares has increased by 23.09% in one year.
| Current Share Class | 10.81M |
| Shares Outstanding | 10.81M |
| Shares Change (YoY) | +23.09% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 67.66% |
| Owned by Institutions (%) | n/a |
| Float | 2.89M |
Valuation Ratios
The trailing PE ratio is 3.99.
| PE Ratio | 3.99 |
| Forward PE | n/a |
| PS Ratio | 0.53 |
| PB Ratio | 0.91 |
| P/TBV Ratio | 0.91 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 6.00 |
| EV / Sales | 0.72 |
| EV / EBITDA | 3.94 |
| EV / EBIT | 4.01 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.34, with a Debt / Equity ratio of 0.33.
| Current Ratio | 2.34 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.33 |
| Debt / EBITDA | 1.04 |
| Debt / FCF | n/a |
| Interest Coverage | 11.52 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 17.15% |
| Return on Capital Employed (ROCE) | 28.31% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 33.81M |
| Profits Per Employee | 4.05M |
| Employee Count | 28 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NSE:BIOPOL has paid 40.40 million in taxes.
| Income Tax | 40.40M |
| Effective Tax Rate | 26.26% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 47.01 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 47.60 |
| Average Volume (20 Days) | 12,240 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:BIOPOL had revenue of INR 946.78 million and earned 113.46 million in profits. Earnings per share was 11.65.
| Revenue | 946.78M |
| Gross Profit | 223.03M |
| Operating Income | 169.95M |
| Pretax Income | 153.86M |
| Net Income | 113.46M |
| EBITDA | 172.99M |
| EBIT | 169.95M |
| Earnings Per Share (EPS) | 11.65 |
Balance Sheet
The company has 1.05 million in cash and 179.64 million in debt, with a net cash position of -178.59 million or -16.53 per share.
| Cash & Cash Equivalents | 1.05M |
| Total Debt | 179.64M |
| Net Cash | -178.59M |
| Net Cash Per Share | -16.53 |
| Equity (Book Value) | 552.27M |
| Book Value Per Share | 51.10 |
| Working Capital | 309.73M |
Cash Flow
In the last 12 months, operating cash flow was -54.30 million and capital expenditures -249.15 million, giving a free cash flow of -303.45 million.
| Operating Cash Flow | -54.30M |
| Capital Expenditures | -249.15M |
| Depreciation & Amortization | 3.05M |
| Net Borrowing | 56.31M |
| Free Cash Flow | -303.45M |
| FCF Per Share | -28.08 |
Margins
Gross margin is 23.56%, with operating and profit margins of 17.95% and 11.98%.
| Gross Margin | 23.56% |
| Operating Margin | 17.95% |
| Pretax Margin | 16.25% |
| Profit Margin | 11.98% |
| EBITDA Margin | 18.27% |
| EBIT Margin | 17.95% |
| FCF Margin | n/a |
Dividends & Yields
NSE:BIOPOL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -23.09% |
| Shareholder Yield | -23.09% |
| Earnings Yield | 25.06% |
| FCF Yield | -60.39% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |